\n| Subject<\/td>\n | \nAnnouncement on behalf of major subsidiary,Excelsior Asset\r\nManagement Co., Ltd., regarding BOD Resolution on capital\r\nincrease by earnings recapitalization<\/pre>\n<\/td>\n<\/tr>\n\n| Date of events<\/td>\n | 2023\/03\/01<\/td>\n | To which item it meets<\/td>\n | paragraph 11<\/td>\n<\/tr>\n | \n| Statement<\/td>\n | \n1.Date of the board of directors resolution:2023\/03\/01\r\n2.Source of capital increase funds:\r\n Earnings recapitalization.\r\n3.Whether to adopt shelf registration (Yes, please \r\n state issuance period\/No):No.\r\n4.Total monetary value of the issuance and number of\r\n shares issued (shares issued not including those \r\n distributed to employees if consisting in capital \r\n increase from earnings or capital surplus):\r\n NT$ 16,240,000 and 1,624,000 shares.\r\n5.If adopting shelf registration, monetary value and\r\n number of shares to be issued this time:\r\n Not Applicable.\r\n6.The remaining monetary value and shares after this\r\n issuance when adopting shelf registration:\r\n Not Applicable.\r\n7.Par value per share:NT$10.\r\n8.Issue price:Not Applicable.\r\n9.Number of shares subscribed for by or allocated to \r\n employees:Not Applicable.\r\n10.Number of shares publicly sold:Not Applicable.\r\n11.Ratio of shares subscribed by or allotted as stock \r\n dividends to existing shareholders:0.019734532 shares\r\n gratuitously allotted for every shares.\r\n12.Handling method for fractional shares and shares \r\n unsubscripted for by the deadline:\r\n If the new shares distributed to shareholders from \r\n this capital increase are less than one full share\r\n (rounded down to the NT dollar), shareholders may\r\n consolidate them by handling respective procedures. \r\n For those shares which cannot be consolidated within\r\n the specified period or still remain insufficient, \r\n and the chairman shall be authorized to designate \r\n specific persons for purchase of these.\r\n13.Rights and obligations of these newly issued shares:\r\n The same as the original shares.\r\n14.Utilization of the funds from the capital increase:\r\n To enhance financial and capital structure.\r\n15.Any other matters that need to be specified:\r\n If the number of shares outstanding is affected and\r\n shareholding ratio is thus affected, the chairman will\r\n be fully authorized for handling such matter.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":" SEQ_NO \u00a04 Date of announcement 2023\/03\/01 Time of announcement \u00a018:11:32 Subject Announcement on behalf of major subsidiary,Excelsior Asset Management Co., Ltd., regarding BOD Resolution on capital increase by earnings recapitalization Date of events 2023\/03\/01 To which item it meets paragraph 11 Statement 1.Date of the board of directors resolution:2023\/03\/01 2.Source of capital increase funds: …<\/p>\n Announcement on behalf of major subsidiary,Excelsior Asset Management Co., Ltd., regarding BOD Resolution on capital increase by earnings recapitalization<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-7135","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/7135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=7135"}],"version-history":[{"count":4,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/7135\/revisions"}],"predecessor-version":[{"id":7139,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/7135\/revisions\/7139"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=7135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=7135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=7135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} | |